Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clinicians. 2022;72:7–33. https://doi.org/10.3322/caac.21708

Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V. Rare breast cancer subtypes: Histological, Molecular, and clinical peculiarities. Oncologist. 2014;19:805–13. https://doi.org/10.1634/theoncologist.2014-0108.

Article  PubMed  PubMed Central  Google Scholar 

Dri A, Arpino G, Bianchini G, Curigliano G, Danesi R, De Laurentiis M, et al. Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs). Cancer Treat Rev. 2024;123:102672. https://doi.org/10.1016/j.ctrv.2023.102672.

Article  CAS  PubMed  Google Scholar 

Barchiesi G, Roberto M, Verrico M, Vici P, Tomao S, Tomao F. Emerging role of PARP inhibitors in metastatic triple negative breast Cancer. Current scenario and future perspectives. Front Oncol. 2021;11:769280. https://doi.org/10.3389/fonc.2021.769280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Zhang F, Liu Z, Fan Z. Immunotherapy for Triple-Negative breast cancer: combination strategies to improve outcome. Cancers (Basel). 2023;15:321. https://doi.org/10.3390/cancers15010321.

Article  CAS  PubMed  Google Scholar 

Vuong B, Darbinian J, Savitz A, Odele P, Perry LM, Sandhu L, et al. Breast cancer recurrence by subtype in a Diverse, contemporary cohort of young women. J Am Coll Surg. 2023;237:13–23. https://doi.org/10.1097/XCS.0000000000000714.

Article  PubMed  Google Scholar 

Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Disease. 2022;14:e1549. https://doi.org/10.1002/wsbm.1549.

Article  CAS  Google Scholar 

Hynes NE, Watson CJ. Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb Perspect Biol. 2010;2:a003186. https://doi.org/10.1101/cshperspect.a003186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francavilla C, O’Brien CS. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer. Open Biology Royal Soc. 2022;12:210373. https://doi.org/10.1098/rsob.210373.

Article  CAS  Google Scholar 

Peng Y, Zhang P, Mei W, Zeng C. Exploring FGFR signaling Inhibition as a promising approach in breast cancer treatment. Int J Biol Macromol. 2024;267:131524. https://doi.org/10.1016/j.ijbiomac.2024.131524.

Article  CAS  PubMed  Google Scholar 

Price J, Francavilla C. The role of fibroblast growth factors in cell and cancer metabolism. FEBS Letters. Cited 24 Nov 2025;n/a. https://doi.org/10.1002/1873-3468.70199

Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends in genetics. Elsevier. 2004;20:563–9. https://doi.org/10.1016/j.tig.2004.08.007.

Article  CAS  Google Scholar 

Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem. 1994;269:11620–7. https://doi.org/10.1016/S0021-9258(19)78170-8.

Article  CAS  PubMed  Google Scholar 

Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proceedings of the National Academy of Sciences. 1992;89:246–50. https://doi.org/10.1073/pnas.89.1.246

Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2. https://doi.org/10.1186/gb-2001-2-3-reviews3005.

Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol. 1991;11:5068–78.

CAS  PubMed  PubMed Central  Google Scholar 

Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways. Proceedings of the National Academy of Sciences. 2001;98:8578–83. https://doi.org/10.1073/pnas.161259898

Dudka AA, Sweet SMM, Heath JK, STAT3 BINDING TO THE FGF RECEPTOR IS ACTIVATED BY RECEPTOR AMPLIFICATION. Cancer Res. 2010;70:3391–401. https://doi.org/10.1158/0008-5472.CAN-09-3033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohrer LR, Chuntova P, Bade LK, Beadnell TC, Leon RP, Brady NJ, et al. Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation. Cancer Res. 2014;74:374–86. https://doi.org/10.1158/0008-5472.CAN-13-2469.

Article  CAS  PubMed  Google Scholar 

Steinfeld R, Van Den Berghe H, David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol. 1996;133:405–16. https://doi.org/10.1083/jcb.133.2.405.

Article  CAS  PubMed  Google Scholar 

Haugsten EM, Zakrzewska M, Brech A, Pust S, Olsnes S, Sandvig K, et al. Clathrin- and Dynamin-Independent endocytosis of FGFR3 – Implications for signalling. PLOS ONE Public Libr Sci. 2011;6:e21708. https://doi.org/10.1371/journal.pone.0021708.

Article  CAS  Google Scholar 

Monsonego-Ornan E, Adar R, Rom E, Yayon A. FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation. FEBS Lett. 2002;528:83–9. https://doi.org/10.1016/S0014-5793(02)03255-6.

Article  CAS  PubMed  Google Scholar 

Negative regulation of FGFR. (Fibroblast Growth Factor Receptor) signaling. Cited 1 Dec 2025. Accessed 1 Dec 2025. https://www.mdpi.com/2073-4409/10/6/1342.

Kovalenko D, Yang X, Nadeau RJ, Harkins LK, Friesel R. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK Activation *. J Biol Chem Elsevier. 2003;278:14087–91. https://doi.org/10.1074/jbc.C200606200.

Article  CAS  Google Scholar 

Li C, Scott DA, Hatch E, Tian X, Mansour SL. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development. 2007;134:167–76. https://doi.org/10.1242/dev.02701.

Article  CAS  PubMed  Google Scholar 

Ranieri D, Nanni M, Persechino F, Torrisi MR, Belleudi F. Role of PKCε in the epithelial-mesenchymal transition induced by FGFR2 isoform switch. Cell Commun Signal. 2020;18:76. https://doi.org/10.1186/s12964-020-00582-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, et al. Molecular insights into the Klotho-Dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007;27:3417–28. https://doi.org/10.1128/MCB.02249-06.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harmer NJ, Pellegrini L, Chirgadze D, Fernandez-Recio J, Blundell TL. The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry. 2004;43:629–40. https://doi.org/10.1021/bi035320k.

Article  CAS  PubMed  Google Scholar 

Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, et al. Tissue-specific expression of betaklotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem. 2007;282:26687–95. https://doi.org/10.1074/jbc.M704165200.

Article  CAS  PubMed  Google Scholar 

Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, et al. Regulation of fibroblast growth Factor-23 signaling by Klotho. J Biol Chem. 2006;281:6120–3. https://doi.org/10.1074/jbc.C500457200.

Article  CAS  PubMed  Google Scholar 

Xie M-H, Holcomb I, Deuel B, Dowd P, Huang A, Vagts A, et al. FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4. Cytokine. 1999;11:729–35. https://doi.org/10.1006/cyto.1999.0485.

Article  CAS  PubMed  Google Scholar 

Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2:217–25. https://doi.org/10.1016/j.cmet.2005.09.001.

Article  CAS  PubMed  Google Scholar 

Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and Leptin-Deficient diabet